Brain Structure and Function in Patients after Metal-on-Metal Hip Resurfacing

REFERENCES

1. 1.↵
   1. Heisel C,
   2. Streich N,
   3. Krachler M,
   4. et al

   . Characterization of the running-in period in total hip resurfacing arthroplasty: an in vivo and in vitro metal ion analysis. J Bone Joint Surg Am 2008;90 (suppl 3):125–33

   Abstract/FREE Full Text
2. 2.↵
   1. Daniel J,
   2. Ziaee H,
   3. Pradhan C,
   4. et al

   . Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty: four-year results of a prospective longitudinal study. J Bone Joint Surg Br 2007;89:169–73

   CrossRefPubMed
3. 3.↵
   1. Duckett S

   . Abnormal deposits of chromium in the pathological human brain. J Neurol Neurosurg Psychiatry 1986;49:296–301

   Abstract/FREE Full Text
4. 4.↵
   1. Höck A,
   2. Demmel U,
   3. Schicha H,
   4. et al

   . Trace element concentration in human brain: activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain 1975;98:49–64

   FREE Full Text
5. 5.↵
   1. Quinteros FA,
   2. Poliandri AH,
   3. Machiavelli LI,
   4. et al

   . In vivo and in vitro effects of chromium VI on anterior pituitary hormone release and cell viability. Toxicol Appl Pharmacol 2007;218:79–87

   CrossRefPubMed
6. 6.↵
   1. Karovic O,
   2. Tonazzini I,
   3. Rebola N,
   4. et al

   . Toxic effects of cobalt in primary cultures of mouse astrocytes: similarities with hypoxia and role of HIF-1alpha. Biochem Pharmacol 2007;73:694–708

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Huk OL,
   2. Catelas I,
   3. Mwale F,
   4. et al

   . Induction of apoptosis and necrosis by metal ions in vitro. J Arthroplasty 2004;19:84–87

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Oldenburg M,
   2. Wegner R,
   3. Baur X

   . Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 2009;24:825 e815–20
9. 9.↵
   1. Rizzetti MC,
   2. Liberini P,
   3. Zarattini G,
   4. et al

   . Loss of sight and sound: could it be the hip? Lancet 2009;373:1052

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Steens W,
    2. von Foerster G,
    3. Katzer A

    . Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip: a case report. Acta Orthop 2006;77:830–32

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Rising JP,
    2. Reynolds IS,
    3. Sedrakyan A

    . Delays and difficulties in assessing metal-on-metal hip implants. N Engl J Med 2012;367:e1

    CrossRefPubMed
12. 12.↵
    1. Hartmann A,
    2. Lutzner J,
    3. Kirschner S,
    4. et al

    . Do survival rate and serum ion concentrations 10 years after metal-on-metal hip resurfacing provide evidence for continued use? Clin Orthop 2012;470:3118–26

    CrossRefPubMed
13. 13.↵
    1. Holland JP,
    2. Langton DJ,
    3. Hashmi M

    . Ten-year clinical, radiological and metal ion analysis of the Birmingham hip resurfacing: from a single, non-designer surgeon. J Bone Joint Surg Br 2012;94:471–76

    CrossRefPubMed
14. 14.↵
    1. Gwilym SE,
    2. Filippini N,
    3. Douaud G,
    4. et al

    . Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum 2010;62:2930–40

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Prentice JR,
    2. Clark MJ,
    3. Hoggard N,
    4. et al

    . Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantation. PloS One 2013;8:e66186

    CrossRefPubMed
16. 16.↵
    1. Bowler RM,
    2. Roels HA,
    3. Nakagawa S,
    4. et al

    . Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 2007;64:167–77

    Abstract/FREE Full Text
17. 17.↵
    1. Lucchini RG,
    2. Albini E,
    3. Benedetti L,
    4. et al

    . High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am J Ind Med 2007;50:788–800

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Patenaude B,
    2. Smith SM,
    3. Kennedy DN,
    4. et al

    . A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907–22

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Graham JM,
    2. Paley MN,
    3. Grunewald RA,
    4. et al

    . Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000;123(pt 12):2423–31

    Abstract/FREE Full Text
20. 20.↵
    1. Miszkiel KA,
    2. Paley MN,
    3. Wilkinson ID,
    4. et al

    . The measurement of R2, R2* and R2′ in HIV-infected patients using the prime sequence as a measure of brain iron deposition. Magn Reson Imaging 1997;15:1113–19

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Wallis LI,
    2. Paley MN,
    3. Graham JM,
    4. et al

    . MRI assessment of basal ganglia iron deposition in Parkinson's disease. Magn Reson Imaging 2008;28:1061–67

    CrossRef
22. 22.↵
    1. Ueno S,
    2. Susa N,
    3. Furukawa Y,
    4. et al

    . Formation of paramagnetic chromium in liver of mice treated with dichromate (VI). Toxicol Appl Pharmacol 1995;135:165–71

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Good CD,
    2. Johnsrude IS,
    3. Ashburner J,
    4. et al

    . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21–36

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW,
    4. et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–19

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Smith SM

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Zhang Y,
    2. Brady M,
    3. Smith S

    . Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Wagner AL,
    2. Murtagh FR,
    3. Hazlett KS,
    4. et al

    . Measurement of the normal optic chiasm on coronal MR images. AJNR Am J Neuroradiol 1997;18:723–26

    Abstract/FREE Full Text
28. 28.↵
    1. Henley SM,
    2. Ridgway GR,
    3. Scahill RI,
    4. et al

    . Pitfalls in the use of voxel-based morphometry as a biomarker: examples from Huntington disease. AJNR Am J Neuroradiol 2010;31:711–19

    Abstract/FREE Full Text
29. 29.↵
    1. Radua J,
    2. Mataix-Cols D,
    3. Phillips ML,
    4. et al

    . A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry 2012;27:605–11

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Genovese CR,
    2. Lazar NA,
    3. Nichols T

    . Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870–78

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Zikou AK,
    2. Kitsos G,
    3. Tzarouchi LC,
    4. et al

    . Voxel-based morphometry and diffusion tensor imaging of the optic pathway in primary open-angle glaucoma: a preliminary study. AJNR Am J Neuroradiol 2012;33:128–34

    Abstract/FREE Full Text
32. 32.↵
    1. Boucard CC,
    2. Hernowo AT,
    3. Maguire RP,
    4. et al

    . Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain 2009;132:1898–906

    Abstract/FREE Full Text
33. 33.↵
    1. Apostoli P,
    2. Catalani S,
    3. Zaghini A,
    4. et al

    . High doses of cobalt induce optic and auditory neuropathy. Exp Toxicol Pathol 2013;65:719–27

    CrossRefPubMed
34. 34.↵
    1. Yang SJ,
    2. Pyen J,
    3. Lee I,
    4. et al

    . Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. J Biochem Mol Biol 2004;37:480–86

    CrossRefPubMed
35. 35.↵
    1. Olivieri G,
    2. Hess C,
    3. Savaskan E,
    4. et al

    . Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion. J Pineal Res 2001;31:320–25

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Wang G,
    2. Hazra TK,
    3. Mitra S,
    4. et al

    . Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells. Nucleic Acids Res 2000;28:2135–40

    Abstract/FREE Full Text
37. 37.↵
    1. de Jong LW,
    2. van der Hiele K,
    3. Veer IM,
    4. et al

    . Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008;131:3277–85

    Abstract/FREE Full Text
38. 38.↵
    1. Gooddy W,
    2. Hamilton EI,
    3. Williams TR

    . Spark-source mass spectrometry in the investigation of neurological disease. II. Element levels in brain, cerebrospinal fluid and blood: some observations on their abundance and significance. Brain 1975;98:65–70

    FREE Full Text
39. 39.↵
    1. Haacke EM,
    2. Cheng NY,
    3. House MJ,
    4. et al

    . Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Langkammer C,
    2. Krebs N,
    3. Goessler W,
    4. et al

    . Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010;257:455–62

    CrossRefPubMedWeb of Science